
Dr. Hawryluk speaks of improving upon tolerability of existing therapies for atopic disease as well as promising new therapies on the horizon.

Dr. Hawryluk speaks of improving upon tolerability of existing therapies for atopic disease as well as promising new therapies on the horizon.

Dr. Erickson discussed screening for children prone to sudden cardiac arrest and sudden cardiac death based on an updated AAP policy statement.

Immigrant children were less likely to be diagnosed with ADHD compared to children of US born parents.

Cohen believes the emergency injection is not only cost-effective but the ideal treatment method for protecting vulnerable pediatric groups with allergies.

The AAP guidelines for ADHD were first released in 2000 and last updated in 2019.

Cohen details some of the diagnostic criteria for anaphylaxis in pediatric populations, differences in symptoms among children and adolescents, and the virtues of epinephrine.

Dr. Michalsky observed challenges in pediatric bariatric surgery, specifically growing consensus on its use, the use of BMI, and access to treatment.

Dr. Michalsky discusses the utility of bariatric surgical options in patients with a high body mass index.

Dr. De Keyser highlights the success of biologics such as omalizumab and dupilumab in the treatment of asthma and atopic dermatitis in pediatric populations.

Dr. Carbone will present during AAP 2021 about managing autism in pediatric practices.

Episode 4 of Crisis Point asks the question you've been waiting for, "What is blueprint to resolving the obesity crisis?"

The treatment is the first FDA approved orally-administered inhibitor of the complement C5a receptor.

Prior to the investigation, peanut allergy was often linked to high rates of anaphylaxis, with its prevalence in children and adolescents surpassing that found in adult patients.

The long-term study from Denmark also found a strong association between gender and loss of asthma control, among other factors.

The most severe outcomes occurred in patients with a history of unhealthy alcohol use.

Data show 5 of 20 patients with history of MBS in the study experienced the primary composite outcome of IMV and/or death by day 7.

Gastrointestinal symptoms were significantly linked to severe symptoms of depression and anxiety.

Differences in CV risk factors persisted between Black participants and White participants and may be due to social determinants of health.

Dr. Fasipe shares her in-person experience viewing Phillip Okwo's Life Interrupted production about living with sickle cell disease.

Investigators from Egypt recorded a high prevalence of stress, anxiety, and depression in patients with vitiligo.

Relapse occurred in 39% of the maintenance group, compared to 56% in the discontinuation group.

Investigators call for pollen monitoring that provides free, continuous, real‐time pollen data representative for any given region.

Factors associated with decreased receipt of ophthalmic telehealth care included older age, male sex, and patients with an educational level of high school or less.

Serious infections occurred in less than 2% of patients treated with the medication during the duration of the 52-week trial.

Delgocitinib is the first and only topical JAK/STAT pathway inhibitor in Japan, and recent data suggests it is effective in the management of atopic dermatitis.

Tramadol is examined alongside codeine to determine if it puts patients at a higher risk of adverse cardiovascular events.

Dr. Lawrence Eichenfield and Dr. David Rosmarin speak to the efficacy of topical ruxolitinib displayed in several trials involving patients with atopic dermatitis and vitiligo.

An unplanned pregnancy can translate into a multitude of health factors and risks for both the mother and the baby.

Investigators also found that patients with alopecia areata were also had significant inflammatory immune injury and vitamin D deficiency when compared to healthy subjects.

Diabetes progression included greater likelihood of insulin treatment initiation, hyperglycemia, glycemic complications, and glucose-lowering prescriptions.